Plant ID: NPO29169
Plant Latin Name: Origanum vulgare
Taxonomy Genus: Origanum
Taxonomy Family: Lamiaceae
NCBI TaxonomyDB:
39352
Plant-of-the-World-Online:
453395-1
Antirheumatic; Antiseptic; Antispasmodic; Aromatherapy; Carminative; Cholagogue; Diaphoretic; Emmenagogue; Expectorant; Odontalgic; Parasiticide; Stimulant; Stomachic; Tonic
Brazil; Afghanistan; Italy; Turkmenistan; Canada; Nepal; Lithuania; France; Ireland; Argentina; Norway; Belarus; Iran; Algeria; Turkey; Venezuela; China; Chile; Belgium; Germany; Iraq; Kazakhstan; Spain; Ukraine; Netherlands; Denmark; Poland; Finland; United States; Morocco; Sweden; Switzerland; New Zealand; Russia; Bulgaria; Pakistan; Romania; Albania; Portugal; Mexico; Tunisia; Tajikistan; India; United Kingdom; Austria; Greece; Hungary; Taiwan; Cyprus
GAA; | |
TRPA1; | |
CA2; CA7; CA4; CA6; CA12; CA1; CA9; CA14; | |
ALOX15; ALDH1A1; | |
PTGS1; | |
MAPT; LMNA; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
Transient receptor potential channel | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | O75762 | CHEMBL6007 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 1.929E-06 | 2.800E-03 | CA2, CA7 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.870E-06 | 2.800E-03 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 1.721E-22 | 3.748E-18 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 4.690E-18 | 5.106E-14 | CA1, CA12, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 4.746E-16 | 2.067E-12 | CA1, CA12, CA2, CA4, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 9.631E-06 | 1.104E-02 | CA1, CA2 |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 2.884E-05 | 3.140E-02 | CA2, CA7 |
BP | GO:0023052; signaling | GO:0032230; positive regulation of synaptic transmission, GABAergic | 4.991E-05 | 4.940E-02 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 4.919E-22 | 1.377E-20 | CA12, CA1, CA2, CA4, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 1.503E-04 | 2.105E-03 | CA2, CA4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 2.406E-04 | 2.245E-03 | ALOX15, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.103E-03 | 6.738E-03 | ALOX15, PTGS1 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.212E-03 | 6.738E-03 | ALDH1A1, CYP3A4 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.223E-03 | 8.893E-03 | GAA, ALOX15, ALDH1A1, CYP3A4, PTGS1 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 1.444E-03 | 6.738E-03 | CA2, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 3.543E-03 | 1.240E-02 | ALOX15, PTGS1 |
09150 Organismal Systems | 09155 Excretory system | hsa04966 | Collecting duct acid secretion | 2.139E-02 | 6.647E-02 | CA2 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 2.374E-02 | 6.647E-02 | GAA |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
NA: NA | Edema | NA | CA2; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |